Could a simple referral to palliative care ease End-of-Life suffering for cancer patients?
NCT ID NCT06150027
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether cancer patients who visit the emergency room for urgent problems benefit from being immediately referred to a palliative care team. The goal is to see if this reduces aggressive treatments and hospitalizations in the last month of life. The trial involves 240 adults with incurable cancer at French cancer centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
systematic referral to a palliative care team
What this could lead to
If successful, this could show that early palliative care referral reduces unnecessary hospitalizations and aggressive treatments near the end of life for cancer patients.
What could go wrong
This is a relatively small study (240 patients) and results may not apply to all cancer centers. The intervention is a referral process, not a drug, so benefits may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Bérard
Lyon, 69008, France
-
ICM Val d'Aurelle
Montpellier, 34090, France
-
Institut Curie - Paris
Paris, 75005, France
-
Institut Curie - Saint Cloud
Saint-Cloud, 92210, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France